Literature DB >> 26702845

Expression and physiology of opioid receptors in the gastrointestinal tract.

Paula Mosińska1, Marta Zielińska, Jakub Fichna.   

Abstract

PURPOSE OF REVIEW: Stimulation of opioid receptors elicits analgesic effect not only in the central nervous system, but also in the gastrointestinal tract, where a high concentration of opioid receptors can be found within the enteric nervous system as well as muscular and immune cells. Along with antinociception, opioid receptors in the stomach and intestine relay signals crucial for secretory and motor gastrointestinal function. RECENT
FINDINGS: The review focuses on the utility of opioid receptor antagonists, which is generally contributing to the management of postoperative ileus and opioid bowel dysfunction in chronic pain patients nonetheless, opioid receptor antagonists can also be useful in the treatment of irritable bowel syndrome and chronic idiopathic constipation. The study also discusses several antidiarrheal opioid agonists, as well as opioids and opioid mimetics encompassing the concept of ligand-biased agonism and truncated opioid receptor splice variants.
SUMMARY: Good understanding of the localization and the role of opioid receptors is vital for regulation of various pathophysiological processes in the gastrointestinal tract and may simultaneously provide a tempting approach in eliminating adverse effects related to centrally acting opioids.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26702845     DOI: 10.1097/MED.0000000000000219

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  12 in total

Review 1.  Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.

Authors:  Ivy Ka Man Law; David Miguel Padua; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-03       Impact factor: 4.052

2.  Diabetics on Narcotics Are Less Likely to Achieve Excellent Bowel Preparation Than Are Patients with Either Condition.

Authors:  Mohammad F Madhoun; Hussein Bitar; Owais Bhatti; Hassaan Zia; Pratyusha Parava; Muhammad H Bashir
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

Review 3.  The placenta as a target of opioid drugs†.

Authors:  Cheryl S Rosenfeld
Journal:  Biol Reprod       Date:  2022-04-26       Impact factor: 4.161

4.  The molecular neurobiology and neuropathology of opioid use disorder.

Authors:  Christopher A Blackwood; Jean Lud Cadet
Journal:  Curr Res Neurobiol       Date:  2021-10-14

5.  Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machine.

Authors:  Dario Kringel; Jörn Lötsch
Journal:  Clin Chim Acta       Date:  2016-10-08       Impact factor: 3.786

6.  Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.

Authors:  Xia Li; Bo Li; Jiaqi Zhang; Ting Chen; Haomeng Wu; Xiaoshuang Shi; Jinxin Ma; Jinyan Qin; Xudong Tang; Fengyun Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

7.  Anti-Inflammatory Effect of Homo- and Heterodimers of Natural Enkephalinase Inhibitors in Experimental Colitis in Mice.

Authors:  Małgorzata Sobocińska; Maciej Salaga; Jakub Fichna; Elżbieta Kamysz
Journal:  Molecules       Date:  2020-12-10       Impact factor: 4.411

8.  The Involvement of the Endogenous Opioid System in the Gastrointestinal Aging in Mice and Humans.

Authors:  Agata Szymaszkiewicz; Marcin Talar; Jakub Włodarczyk; Mikołaj Świerczyński; Adrian Bartoszek; Julia Krajewska; Anna Mokrowiecka; Ewa Małecka-Wojciesko; Jakub Fichna; Marta Zielińska
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 9.  Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue.

Authors:  Giovannamaria Petrocelli; Luca Pampanella; Provvidenza M Abruzzo; Carlo Ventura; Silvia Canaider; Federica Facchin
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 10.  Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea.

Authors:  Konstantinos C Fragkos
Journal:  Clin Exp Gastroenterol       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.